BGI Genomics Plans to Raise CNY 2 billion to Expand Diagnosis Project
BGI Genomics (300676:SZ) announced that it planned to raise a fund of up to CNY 2.12 billion for a series of diagnosis-related projects. This bankroll will be used for the diagnostics kits production, platform establishment, cloud data system and sample pool construction.
The issuance will be provided to fewer than 35 particular investors, including fund managers, securities companies, trustees, financial advisory companies, insurers, qualified inbound and outbound investors.
This text is a result of machine translation.
Related companies：
In-depth
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Aug 05, 2021 08:49 PM
· Healthcare
Tianneng heavy industry: in order to further promote the expansion of the company's industrial chain, it plans to set up a subsidiary in Hong Kong
Healthcare · Analysis
Open Source, Open Mind: Baidu and LinkingMed Help Doctors in Medical Images
A Chinese startup, based on Baidu’s deep-learning open-source platform PaddlePaddle, is providing CT screening service to a Hunan-based hospital, hoping to facilitate the diagnosis process.
Mar 05, 2020 11:41 AM
Su'ao sensor: the shareholding ratio of Wang Wenqiao, the shareholder, was passively diluted to 1.1%
Briefing Dec 28, 2020 02:44 PM
· Healthcare
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
See more
Read next
Insight
In-depth
Automotive · Analysis
Chinese Automakers Break into a €10 Billion Market in Europe
Apr 11, 2025 09:57 PM
Insight
In-depth
Automotive · Analysis
Tariff Escalation Through the Lens of Geopolitical Economy
Apr 11, 2025 12:32 PM
Insight
In-depth
Consumer Staples · Analysis
China’s “Dark Cuisine” and Southeast Asia’s Wealth Code
Apr 07, 2025 03:46 PM
Insight
In-depth